Conference Coverage

Conference Coverage

Dalcetrapib Boosts HDL Without Bumping BP

Major Finding: Dalcetrapib increased HDL cholesterol levels by 31%, compared with placebo.Data Source: Phase IIb randomized trial in 476 patients...

Pages